Changzhou Qianhong Bio-pharma Co., Ltd.

Established in 1971, Changzhou Qianhong Bio-pharma is a state high-tech manufacturer of enzyme and polysaccharide biopharmaceuticals, and the largest injectable heparin sodium manufacturer in China, holding more than 25% market share in Europe. Its raw heparin crude is sourced from qualified, traceable suppliers, with PCR and electrophoresis testing performed on every batch to ensure quality. Main products include kallidinogenase (pancreatic kininogenase) tablets and API, heparin sodium, low-molecular-weight heparins (enoxaparin, dalteparin, nadroparin), enoxaparin and dalteparin sodium prefilled syringes, and asparaginase API and injectable formulation.